Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Chronic Spontaneous Urticaria (Disease Or Phenotype)

Msh:D000080223

Mondo:MONDO:44212

Medcin:MEDCIN:418877

Mdr:MDR:10072758

Id:a80a925e-2674-531c-95d7-976623153950

Results found

Linked to

	Label	Description
	(<i>R</i>)-cetirizine indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	4-(4-Benzhydryloxy-piperidin-1-yl)-1-(4-tert-butyl-phenyl)-butan-1-one indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	fexofenadine indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Loratadine indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	terfenadine indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yl]-{1-[2-(4-methoxy-phenyl)-ethyl]-piperidin-4-yl}-amine indication Chronic Spontaneous Urticaria Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(<i>R</i>)-cetirizine indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

4-(4-Benzhydryloxy-piperidin-1-yl)-1-(4-tert-butyl-phenyl)-butan-1-one indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

fexofenadine indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Loratadine indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

terfenadine indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yl]-{1-[2-(4-methoxy-phenyl)-ethyl]-piperidin-4-yl}-amine indication Chronic Spontaneous Urticaria

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.